More than one-third of cases at United Surgical Partners International, Tenet Healthcare's ASC chain, were orthopedic in 2022.
Thirty-six percent of USPI's 2022 case were musculoskeletal, followed by gastrointestinal cases, which made up 34 percent of the mix, according to a second-quarter report from Tenet.
During the second quarter of 2023, USPI saw growth in orthopedic volumes, Tenet CEO Saum Sutaria, MD, said in a July 31 earnings call, as transcribed by Seeking Alpha. Outpatient total joint replacement volume rose 12 percent year over year.
Dallas-based Tenet posted net income of $123 million in the second quarter of 2023.